Summary: Apoptosis or programmed cell death may be involved in neuronal death in the cerebral cortex after a permanent focal ischemic insult. Studies indicate that protein p53 is a major determinant of the cellular mech anism that leads to programmed cell death. Wild-type C57 mice and two groups of transgenic C57 mice, one ho mozygous and the other heterozygous for a p53 null gene, were subjected to middle cerebral artery occlusion. As expected, the wild-type mice had a large, consistent in farct volume (22.11 ± 4:59 mm3; n = 10). Both transgenic groups had significantly less ischemic damage than the wild-type control group. However, unexpectedly, the The damage to cerebral tissue incurred from an ischemic event has long been considered to be due to necrotic mechanisms (Brown, 1977; Schwartz and Osborne, 1993) . Indeed, the severity of the dis ruption of blood flow in the ischemic focus most likely results in pannecrosis of this tissue. How ever, necrosis is only one of two means by which cells may die. The second mechanism is known as programmed cell death (PCD) and has been exten sively described in developmental biology (Saun ders, 1966; Buja et aI., 1993). In PCD, the cell ini tiates a series of steps requiring gene activation and protein synthesis to systematically control the cell's own destruction. Thus, these collective steps result in cellular suicide. Protein p53 has been identified as a potential initiator of the suicide program (Y on- 
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ish- Rouach et al., 1991; Clarke et al., 1993; Lowe et al., 1993; Rayan et al., 1993; Schimke and Mihich, 1994) . For example, in a murine myeloid leukemic cell line that lacks p53 expression, the introduction and activation of the p53 gene induced the cells to undergo changes characteristic of apoptosis (a form of programmed cell death; Yonish-Rouach et aI., 1991) . However, p53 may not be involved in all forms of apoptosis because thymocytes homozy gous for a null p53 allele are resistant to gamma radiation and etoposide, but not glucocorticoid nor phorbol myristoyl 13-acetate (PMA)/ionomycin, in duced apoptosis. Gamma irradiation and etoposide cause significant DNA damage, which may be the trigger for p53 mediated apoptosis (Lowe et al., 1993; Clarke et al., 1993) .
Whether or not apoptosis is important in focal cerebral ischemic damage is unclear. However, in creased p53 staining by immunohistochemistry was observed in damaged cortical and striatal tissue of rats after 12 h of reflow after 2 h of focal cerebral ischemia. The contralateral hemisphere showed no significant p53 staining (Chopp et al., 1992; Li et al., 1994) . Recently, the presence of "DNA ladders" was observed when DNA from ischemic brain tis sue was electrophoresed on agarose gels (Tominaga et aI., 1993; Linnik et aI., 1993) . The "DNA lad ders" are the result of endonuclease activity, which degrades cellular DNA in multiples of 185-200 base pairs and is a characteristic of apoptosis. However, because of the temporal discrepancy between irre versible tissue damage and the first appearance of DNA ladders, Tominaga et aI. (1993) caution about using DNA ladders as the sole evidence of apopto sis in ischemic pathology. Endonuclease activity has been observed after global cerebral ischemia with reperfusion and may be a factor in delayed neuronal death (DND) (MacManus et aI., 1993; Okamoto et aI., 1993; Heron et aI., 1993) . In addi tion, it was demonstrated that inhibition of protein synthesis may provide some protection of cerebral tissue from focal (Linnik et aI., 1993) and global ischemic damage (Shigeno et aI., 1990) . This would be expected if apoptosis is a major cause of neuro nal death because de novo protein synthesis is re quired in most forms of PCD. However, the role of apoptosis in DND has been challenged because the histological profile does not fit and the ameliorating effects of protein synthesis inhibitors can be miti gated if the brain temperature is controlled (Desh pande et aI., 1992) .
Because of the central role of p53 expression in the initiation of some forms of apoptosis and be cause increased p53 protein has been observed in brain tissue after ischemia, we postulated that if apoptosis is a major cause of ischemic cell death, then animals lacking the gene for p53 should have reduced brain damage after stroke. This is because without p53 expression, their cells would be unable to initiate the gene sequence for PCD. We tested this hypothesis by subjecting C57 mice transgenic for a null p53 allele to focal cerebral ischemia.
MATERIALS AND METHODS

Transgenic mice
Transgenic C57 mice were obtained from GenPharm International (Mountain View, CA, U.S.A.) at 1 month of age. The mice were transgenic for a null allele construct of the p53 gene. The construction of the null allele and the production of the transgenic mice has been described in detail by Donehower et al. (1992) . The homozygous trans genic mice had two null p53 genes and thus were devoid of p53 protein. The heterozygous mice had one copy of the wild-type gene and one copy of the null gene con struct. Wild-type mice had two normal copies of the gene. These three groups will be referred to as the homozygous, heterozygous, and wild-type groups throughout the rest of the article. Each mouse was genotyped by the supplier before shipment.
The mice were housed in individual cages in our animal facilities and acclimated for 1 week before experimenta-J Cereb Blood Flow Me/ab, Vol. 14, No. 6, 1994 tion. They were on a 12-h light/dark diurnal cycle. Food was provided ad libitum. All procedures were reviewed and approved by our Institutional Animal Care and Use Committee before performance of the experiment.
Surgical procedure
Focal cerebral ischemia was produced in the mice by modification of the procedure described by Welsh et al. (1987) . The mice were anesthetized with ketamine (125 mg/kg, i.p.) and xylazine (10 mg/kg, i,p.). Body temper ature was monitored and maintained between 3r and 38°C by a heat lamp. Occlusion of the left middle cerebral artery (MCA) was accomplished by ligation of the artery with 10--0 suture at the level of the inferior cerebral vein. Sham animals had the 10--0 suture passed underneath the artery. Gelfoam was placed in the bony deficit and the temporalis muscle was allowed to fall back into place. The skin wound was closed with 5-0 silk suture and the mice were allowed to recover from anesthesia in their home cages. For the next 48 h a heating lamp was posi tioned above the cages to increase the local ambient tem perature. This allowed the mice to more easily autoregu late their body temperature, Each mouse was checked periodically during the 48 h after surgery to ensure nor mothermia, The mice required no special care throughout the recovery period. To limit interoperator variability, all of the surgeries were performed by one surgeon.
Forty-eight hours after MCA occlusion, the mice were anesthetized with halothane in an anesthesia box and de capitated. The brains were removed from the calvarium and were frozen in methylbutane cooled to -30°C. The brains were stored at -8SOC until sectioned.
Histology
Twenty-micron frozen sections were obtained every 400 or 500 fJ-m and were stained with hematoxylin and eosin. Sections were obtained from the most rostral to the most caudal aspects of the neocortex. The area of isch emic damage was well defined by staining pallor. The measurement of the area of damage of each section was performed by image analysis (NIH Image 1.45). The area of pallor of successive sections were averaged and mul tiplied by the known distance between the sections (Du verger and MacKenzie, 1988 ; with modification). The volume of the contralateral and ipsilateral hemispheres were determined in a similar fashion. For consistency, one person performed all of the measurements.
The infarct volume was adjusted for edema by the method proposed by Leach et al. (1993) . The gross infarct volume was multiplied by the contralateral/ipsilateral hemisphere ratio.
Statistics
All of the volume comparisons between groups were analyzed by the Kruskal-Wallis test for nonparametric data. Comparison of the ipsilateral to contralateral hemi spheres within groups were analyzed by independent t
test. An alpha value of 0.05 or less was considered sig nificant. All of the surgeries, measurements, and final data analysis were performed by researchers blind to the identity of the experimental groups.
RESULTS
The body weights between the groups were very similar (Table O. The contralateral/ipsilateral hemi- sphere ratio (C/I ratio) for the nonsurgical control group (Table 1, Control) was 1, indicating that the size of the two hemispheres of normal mice is es sentially identical. The C/I ratio of the sham group, although < 1, was not significantly different from the nonsurgical controls. The C/I ratio of the oc cluded groups was significantly different from that of the sham and control groups. The mathematical difference ( Table I , Dift) between the ipsilateral and contralateral hemispheres of the sham ,and nonsur gical control groups was significantly less than the values for the three experimental groups (p < 0.05, Kruskal-Wallis). The total brain volume of the sham animals was slightly larger than the heterozygous and homozygous groups. The wild-type ipsilateral hemisphere volume Was significantly larger than that of the heterozygous group (p < 0.05, Kruskal Wallis). The ipsilateral hemisphere was signifi cantly larger than the contralateral hemisphere in the wild type, heterozygous, and homozygous groups (p < 0.05, independent t test). Figure 1 shows the infarct volumes of the three experimental groups. The values displayed were corrected for edema as described by Leach et al. (1993) . The wild-type mice had a large consistent infarction of the left neocortex (22.11 ± 4.59 mm 3 , n = 10). The infarct size of the homozygous group (18.72 ± 3.48 mm 3 , n = 9) was significantly smaller than the wild type group (p = 0.042, Kruskal Wallis; 15% reduCtion). The heterozygous group had a smaller infarct size (16.12 ± 1.71 mm 3 , n = 10) than either the wild type (p < 0.01, Kruskal Wallis, 27% reduction) or homozygous (p < 0.05, Kruskal-Wallis, 14% reduction) groups. Statistical analysis of the raw infarct volumes mimicked that of the infarct size corrected for edema (compare pallor volume in Table 1 with Fig. 1 ).
DISCUSSION
The production and characterization of the trans genic mice used in these studies have been exten sively described by Donehower et al. (1992) . Em bryologically, the homozygous and heterozygous mice develop normally and are morphologically identical to the wild-type mice. Immunobloting for p53 along with DNA-polymerase chain reaction (PCR) and RNA-PCR assays confirmed the com plete lack of functional p53 gene in the homozygous mice. The heterozygous and wild-type mice were positive for p53 in all three assays. The major dis tinguishing characteristic between the three groups was the incidence of spontaneous tumors. The ho- mozygous animals developed various neoplasms by 6 months of age and they had shorter life spans than the other two groups. Although not as early or as frequent as the homozygotes, the heterozygotes were more susceptible to tumors than the wild-type mice. This progression of tumor susceptibility most likely reflects the difference in p53 gene dose be tween the three groups of mice (see Donehower et aI., 1992 for further details). A p53 gene dose de pendency was also observed in the resistance of thymocytes from wild-type, heterozygous, and ho mozygous mice to gamma radiation and etoposide induced apoptosis (Lowe et aI., 1993; Clarke et aI., 1993) . After a focal ischemic insult, the neurons receive and respond to many extracellular and intracellular signals-many of which may be both conflicting and inappropriate for the immediate circumstances. An inappropriate signal may specify for neuronal cells to initiate the sequelae leading to cellular death known as apoptosis. Evidence suggests that p53 may be an initial signal for cells to begin this pro cess of PCD (Y onish-Rouach et aI., 1991; Clarke et aI., 1993; Lowe et aI., 1993; Rayan et aI., 1993; Schimke and Mihich, 1994) . Thus, if neuronal cells were unable to produce p53, they should be resis tant to ischemic damage. Consistent with this pre diction, mice homozygous for a null p53 allele and thus, unable to produce p53, had significantly less brain damage after stroke than wild-type controls. Surprisingly, the heterozygous mice had signifi cantly less ischemic damage than the homozygous group. These data suggest that under certain cir cumstances, p53 may have several opposing roles, some of which may be protective after an ischemic insult. These data suggest that whether p53 is pro tective or not may depend on the gene dose of the protein.
The mechanism by which p53 may be protective after ischemia is speculative at best, however, it may relate to the ability of p53 to suppress cell cycle progression (Vogel stein and Kinzler, 1992) . Isch emia may induce neuronal cells to reenter a defec tive cell cycle. p53 may arrest the cell cycle, shifting the neurons back to Go. Alternatively, reduced or no capacity to produce p53 during the embryologi cal development of the transgenic mice may confer resistance to ischemic damage. For example, a dif ference in the general physiology or perhaps a de velopmental change in the structural architecture of the cerebral circulation may account for the in creased resistance to ischemia of the transgenic mice. This seems unlikely and does not readily ex plain the lack of correlation of neuroprotection from ischemic stroke with p53 gene dose (i.e., if these J Cereb Blood Flow Metab, Vol. 14, No. 6, 1994 factors were involved, then the homozygotes should have the least amount of ischemic damage).
The severe reduction in blood flow to the core of a focal ischemic insult results in necrosis of this tissue within Yz h (unpublished observations). There is a steady expansion of ischemic damage for the next 4-6 h in rats (Buchan et aI., 1992; unpublished observations) . Although the temporal profile of p53 expression in permanent focal cerebral ischemia re mains to be elucidated, induction of p53 mRNA has been detected after 6 h of reperfusion after 2 h of focal ischemia (Li et aI., 1994) . Thus, p53 can be induced in ischemic tissue and may play a role in the growth of ischemic damage (excluding the isch emic core).
Our results clearly demonstrate a role for p53 in ischemic pathology. Paradoxically, too much p53 results in maximal pathology whereas the total ab sence of p53 is only marginally protective. Cells may need moderate expression of p53 for maximal protection. Although the temporal aspects of p53 in ischemic brain injury remain to be defined, p53 pre sents an interesting and potentially very fruitful tar get for therapeutic intervention after an ischemic event.
